Drug discovery: New Btk inhibitor holds promise. (Q54626187)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Drug discovery: New Btk inhibitor holds promise.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

Drug discovery: New Btk inhibitor holds promise. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

1 reference

based on heuristic

inferred from title

author name string

Rudi W Hendriks

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

Nature Chemical Biology

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

4-5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cells as therapeutic targets in SLE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B cell signaling and tumorigenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21164510

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NCHEMBIO.502

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21164510

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54626187&oldid=2212540662"